Merck (MRK) Acquisitions (2009 - 2026)
Merck (MRK) reported Acquisitions of $8.8 billion for Q1 2026, down 12.58% quarter-over-quarter from $10.0 billion in Q4 2025.
Merck (MRK) Acquisitions (2009 - 2026) Analysis & Trends
Merck (MRK) has 15 years of Acquisitions data on file, last reported at $8.8 billion in Q1 2026.
- Acquisitions for Q1 2026 came in at $8.8 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $18.8 billion (up 2622.92% YoY), and the FY2025 annual result was $10.0 billion, changed N/A from the prior year.
- Acquisitions slipped to $8.8 billion in Q1 2026 per MRK's latest filing, from $10.0 billion in the prior quarter.
- Over five years, Acquisitions peaked at $10.0 billion in Q4 2025 and troughed at -$1.3 billion in Q4 2024.
- A 4-year average of $2.7 billion and a median of $598.0 million in 2024 frame the typical range for Acquisitions.
- On a YoY basis, Acquisitions climbed as much as 12200.0% in 2022 and fell as far as 234.44% in 2022.
- A 4-year view of Acquisitions shows it stood at -$121.0 million in 2022, then tumbled by 1010.74% to -$1.3 billion in 2024, then soared by 847.17% to $10.0 billion in 2025, then fell by 12.58% to $8.8 billion in 2026.
- Business Quant data shows MRK's Acquisitions at $8.8 billion in Q1 2026, $10.0 billion in Q4 2025, and -$1.3 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -1.89 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | - |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 8.78 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 109.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 65.00 Mn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.78 Bn |
| Dec 31, 2025 | 10.04 Bn |
| Dec 31, 2024 | -1.34 Bn |
| Sep 30, 2024 | 598.00 Mn |
| Mar 31, 2024 | 746.00 Mn |
| Dec 31, 2022 | -121.00 Mn |
| Sep 30, 2022 | 121.00 Mn |
| Dec 31, 2021 | 90.00 Mn |
| Sep 30, 2021 | -1.00 Mn |
| Jun 30, 2021 | 76.00 Mn |
| Mar 31, 2021 | 14.00 Mn |
| Dec 31, 2020 | 458.00 Mn |
| Sep 30, 2020 | 586.00 Mn |
| Jun 30, 2020 | 321.00 Mn |
| Dec 31, 2019 | 25.00 Mn |
| Sep 30, 2019 | -1.00 Mn |
| Jun 30, 2019 | 270.00 Mn |
| Dec 31, 2018 | 59.00 Mn |
| Jun 30, 2018 | 372.00 Mn |
| Dec 31, 2017 | 49.00 Mn |